We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTS
2651
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $916K | ﹤0.01% |
138,015
+12,447
| +10% | +$83.8K |
|
|
CBAY
2652
DELISTED
Cymabay Therapeutics
CBAY
| $913K | ﹤0.01% |
261,718
-131,867
| -34% | -$381K |
|
2653
Rayonier Advanced Materials
RYAM
$610M
| $912K | ﹤0.01% |
324,324
+106,372
| +49% | +$204K |
|
2654
Sprout Social
SPT
$621M
| $910K | ﹤0.01% |
33,688
+18,519
| +122% | +$406K |
|
2655
Lifecore Biomedical
LFCR
$190M
| $908K | ﹤0.01% |
114,076
+13,064
| +13% | +$135K |
|
|
AMNB
2656
DELISTED
American National Bankshares Inc
AMNB
| $908K | ﹤0.01% |
36,255
-1,466
| -4% | -$35.1K |
|
|
RJET
2657
Republic Airways Holdings
RJET
$1B
| $904K | ﹤0.01% |
17,529
-506
| -3% | -$26.8K |
|
2658
Fulcrum Therapeutics
FULC
$297M
| $902K | ﹤0.01% |
49,362
+13,532
| +38% | +$213K |
|
|
REVG
2659
DELISTED
REV Group
REVG
| $901K | ﹤0.01% |
147,724
+4,533
| +3% | +$24.3K |
|
2660
Movado Group
MOV
$841M
| $899K | ﹤0.01% |
82,933
-12,155
| -13% | -$131K |
|
2661
Willdan Group
WLDN
$1.3B
| $899K | ﹤0.01% |
35,976
-7,580
| -17% | -$174K |
|
2662
Acacia Research
ACTG
$470M
| $897K | ﹤0.01% |
219,325
+16,551
| +8% | +$48K |
|
|
NBSE
2663
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $890K | ﹤0.01% |
+5,072
| New | +$849K |
|
|
LTRPA
2664
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $888K | ﹤0.01% |
416,817
-399,122
| -49% | -$910K |
|
|
AGRX
2665
DELISTED
Agile Therapeutics
AGRX
| $888K | ﹤0.01% |
+160
| New | +$831K |
|
|
IVC
2666
DELISTED
Invacare Corporation
IVC
| $887K | ﹤0.01% |
139,108
-286,134
| -67% | -$1.91M |
|
|
TAST
2667
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $886K | ﹤0.01% |
183,171
+28,808
| +19% | +$109K |
|
|
ARD
2668
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $885K | ﹤0.01% |
68,558
-16,306
| -19% | -$203K |
|
2669
Consolidated Water Co
CWCO
$488M
| $873K | ﹤0.01% |
60,508
+5,395
| +10% | +$79K |
|
2670
Hingham Institution for Saving
HIFS
$663M
| $873K | ﹤0.01% |
5,204
-1,140
| -18% | -$177K |
|
2671
Spero Therapeutics
SPRO
$73M
| $873K | ﹤0.01% |
64,563
+20,510
| +47% | +$230K |
|
2672
SiTime
SITM
$21.8B
| $872K | ﹤0.01% |
+18,407
| New | +$546K |
|
2673
Hooker Furnishings Corp
HOFT
$166M
| $871K | ﹤0.01% |
44,805
-40,871
| -48% | -$654K |
|
2674
AMC Entertainment Holdings
AMC
$2.31B
| $869K | ﹤0.01% |
20,265
-1,244
| -6% | -$54.4K |
|
|
FRGI
2675
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $869K | ﹤0.01% |
136,316
+35,770
| +36% | +$248K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.